Almansa C, de Arriba A F, Cavalcanti F L, Gómez L A, Miralles A, Merlos M, García-Rafanell J, Forn J
Research Center, J. Uriach & Cía. S.A., Barcelona, Spain.
J Med Chem. 2001 Feb 1;44(3):350-61. doi: 10.1021/jm0009383.
The synthesis and pharmacological activity of a series of bicyclic pyrazolo[1,5-a]pyrimidines as potent and selective cyclooxygenase-2 (COX-2) inhibitors are described. The new compounds were evaluated both in vitro (COX-1 and COX-2 inhibition in human whole blood) and in vivo (carrageenan-induced paw edema and air-pouch model). Modification of the pyrimidine substituents showed that 6,7-disubstitution provided the best activity and led to the identification of 3-(4-fluorophenyl)-6,7-dimethyl-2-(4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidine (10f) as one of the most potent and selective COX-2 inhibitor in this series.
描述了一系列双环吡唑并[1,5 - a]嘧啶作为强效和选择性环氧合酶 - 2(COX - 2)抑制剂的合成及药理活性。这些新化合物在体外(人全血中COX - 1和COX - 2抑制)和体内(角叉菜胶诱导的爪肿胀和气袋模型)进行了评估。嘧啶取代基的修饰表明,6,7 - 二取代提供了最佳活性,并鉴定出3 - (4 - 氟苯基)-6,7 - 二甲基 - 2 - (4 - 甲磺酰基苯基)吡唑并[1,5 - a]嘧啶(10f)是该系列中最有效和选择性最强的COX - 2抑制剂之一。